1/11
Looks like no tags are added yet.
neural correlates
Neural correlates of schizophrenia are the particular brain areas, structures, or functions that are linked to symptoms and behaviours characteristic of the disorder
Neural correlates of negative symptoms:
The ventral striatum (part of the limbic system, associated with the anticipation of reward) has been associated with the negative symptoms of schizophrenia e.g. abolition (lack of motivation to initiate and persist in goal-directed behaviour)
Kirschener et al. (2016) found that schizophrenic patients show less activity in the ventral striatum, which is associated with apathy
Neural correlates of positive symptoms:
The superior temporal gyrus (STG), which is thought to control the processing of speech, has been associated with positive symptoms of schizophrenia e.g. hallucinations
Allen et al. (2007) found lower activation levels in the STG and anterior cingulate gyrus (ACG) in the brains of patients experiencing hallucinations whilst they completed and auditory processing task
Rajarethinam et al. (2000) found that schizophrenic patients show reduced volumes of grey matter in the STG, which is associated with hallucinations and though disorder
van rossen’s dopamine hypothesis
The dopamine hypothesis is a theory, first suggested by Van Rossum (1966), which claims that an overstimulation of dopamine receptors may be a contributory factor to a person’s vulnerability to schizophrenia
The original version of the DH suggests the idea that hyperdopaminergia (abnormally high levels of dopamine) in the sub-cortex may be responsible for the onset of schizophrenia
Hyperdopaminergia assumes that an excess of dopamine is active in areas such as the amygdala, basal ganglia, hippocampus, and nucleus accumbens, which creates an altered perception of the world
E.g. positive symptoms such as auditory hallucinations could be caused by hyperdopaminergia in Broca’s area, which regulates speech production
Van Rossen’s DH was supported by research which showed that dopamine antagonists, which blocked the dopamine pathways, were linked to a reduction in positive schizophrenic symptoms
newer version of the dopamine hypothesis
The newer version of the DH posits the idea that hypodopaminergia (abnormally low levels of dopamine) in the prefrontal cortex may be responsible for the onset of schizophrenia
The PFC is thought to control and regulate executive functions such as information processing, rational thought, and decision-making
Hypodopaminergia assumes that low levels of dopamine in the PFC are linked to negative symptoms such as speech poverty, as the PFC plays a role in logical thinking, and low levels of dopamine may lead to the inability to construct grammatical sentences
Current understanding of the role of dopamine in schizophrenia is that both hyperdopaminergia and hypodominergia may be at work in different brain areas to produce schizophrenia
strengths of the dopamine hypothesis
The dopamine hypothesis is supported by empirical evidence gathered using different methods which point to the same conclusion, e.g. Davis et al. (1991), Lindstroem (1999), Donnelly et al. (1996), Rege (2018)
weaknesses of the dopamine hypothesis
The dopamine hypothesis is biologically reductionist, as it simplifies the cause of schizophrenia, to genes and neural correlates - it can explain how but not why these biological differences that are implicated in schizophrenia are caused in the first place
littrell & schneiderhan (1996)
Littrell & Schneiderhan (1996)
Found that the antipsychotic drugs clozapine and risperidone act as dopamine antagonists and are associated with a reduction of adverse schizophrenia symptoms
davis et al. (1991)
Davis et al. (1991)
Found that schizophrenia is linked to hypodopaminergia in the PFC, which leads to hyperdopaminergia in the sub-cortex - meaning both hypodopaminergia and hyperdopaminergia are implicated in schizophrenia
lindstroem (1999)
Lindstroem (1999)
Used PET scans on 10 untreated schizophrenics and 10 non-schizophrenics
They injected the participants with a radioactively labelled chemical L-DOPA, which is used by the body for the production of dopamine
The PET scans found that the L-DOPA was taken up more quickly in the schizophrenics, which suggests that there was more dopamine being produced in these individuals
rege (2018)
Rege (2018)
Found that increased dopamine in the mesolimbic pathway leads to positive symptoms
The mesolimbic pathway runs from the ventral tegemental area to the nucleus accumbens and is responsible for reward, motivation and assigning importance to stimuli
Rege also found that that decreased dopamine in the mesocortical pathway leads to the negative symptoms of schizophrenia
The mesocortical pathway is involved in thinking, decision-making and emotional regulation - it runs from the ventral tegemental area to the prefrontal cortex (PFC0
Rege also states that dopamine alone cannot account for schizophrenia and that there appears to be glutamate dysfunction as well as neurodevelopmental factors
strengths of neural correlates of schizophrenia
The use of brain-imaging techniques such as PET, MRI and fMRI provides objective evidence for neural correlates of schizophrenia as they pinpoint specific brain structures implicated in the symptoms of the disorder
Brain-imaging technologies are conducted under controlled clinical conditions, which means that they are likely to show consistent result over time, supporting their reliability
weaknesses of neural correlates of schizophrenia
The research evidence for neural correlates takes a correlational approach to mapping brain regions in schizophrenia, which means that it lacks a cause-and-effect explanation
We can also question the direction of correlation, as it could be that the difference in activity levels could be a consequence of the disorder, not the cause of it
There is no acknowledgment of the role of the environment in this explanation of schizophrenia, meaning it lacks external validity
links of neural correlates explanation of schizophrenia to issues & debates
The neural correlates explanation is reductionist, as it reduces schizophrenia to brain structures and neurochemical activity, which may limit the development of holistic treatment approaches
The neural correlates explanation supports a biological determinist view, suggesting that abnormal brain structures and imbalanced dopamine levels determine the onset of schizophrenia
This can be ethically problematic, particularly in legal or clinical contexts where responsibility and personal agency are considered